| Financial Year |
March 31 2020 |
| Monetary Funds |
123,104,674.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,724,200.50 |
| Accounts Receivable |
479,296,395.75 |
| Advances to Suppliers |
743,976,164.24 |
| Other Receivables |
107,211,610.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,143,040.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,510,456,086.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,527,116,251.32 |
| Under-construction Projects |
1,565,732.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,709,186.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
60,410.00 |
| Deferred Income Tax Assets |
904,215.04 |
| Other Non-Current Assets |
19,278,614.60 |
| Sub-Total of Non-Current Assets |
1,671,424,289.46 |
| Total Assets |
3,181,880,375.72 |
| Short-Term Loans |
73,409,280.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
41,307,277.43 |
| Accounts Received In Advance |
554,557.09 |
| Employee Compensation Payable |
5,410,595.83 |
| Taxes Payable |
32,892,537.91 |
| Interest Payable |
362,128,031.69 |
| Dividend Payable |
-- |
| Other payables |
499,008,334.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,900,528,395.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,553,110,977.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
45,000,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
213,858,163.54 |
| Total Liabilities |
2,766,969,141.26 |
| Paid-In Capital(Or Share Stock) |
766,480,153.00 |
| Capital Surplus |
788,995,568.04 |
| Surplus Reserve |
140,558,999.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,270,590,146.04 |
| Minority Stockholder's Interest |
-907,744.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
415,818,978.52 |
| Owner's Equity（Stockholder's Equity） |
414,911,234.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,181,880,375.72 |
